1
Mayo Clio Proc, May 1995, Vol 70 nonhemorrhagic stroke; a ventilation/perfusion scan showed a high probability of pulmonary embolism. A correct option indicated was to begin intravenous heparin therapy to in- crease the activated partial thromboplastin time to 1 1 /2 times the normal value and start warfarin therapy the same day. I believe, however, that it is important, especially for teaching purposes, to consider the option of obtaining a computed tomographic scan of the head. Possibly, a cerebral computed tomographic scan was obtained only during the initial as- sessment of the patient, results of which showed no acute hemorrhage. Thus, the patient's hemiplegia would have been regarded as due to a nonhemorrhagic cause. Consider- ing the clinical entity of hemorrhagic transformation of a cerebrovascular accident is important. This well-described entity can occur in previously ischemic brain tissue within 10 days after an initial ischemic event. The initiation of anticoagulant therapy in the presence of a cerebral hemorrhagic event would be devastating. In my opinion and from my clinical experience, the option of per- forming imaging studies of the head should therefore be considered as a first step before instituting anticoagulant therapy in such a situation. Martin A. Schaeffer, M.D. DuBois Regional Medical Center DuBois, Pennsylvania In response: I agree entirely with Dr. Schaeffer's concerns that a stroke may not demonstrate hemorrhage for at least 48 hours. Thus, obtaining a computed tomographic scan before initiation of long-term anticoagulant therapy would be appropriate. Edward C. Rosenow III, M.D. Mayo Clinic Rochester Rochester, Minnesota Treatment of Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy To the Editor: In the case report by Kwo and Tremaine on nonsteroidal anti-inflammatory drug-induced enteropathy, which was published in the January 1995 issue of the Mayo Clinic Proceedings (pages 55 to 61), I question their decision to perform laparotomy in their patient who had persistent anemia. Their article had several references that substanti- ated the effects of nonsteroidal anti-inflammatory drugs on the small bowel. In the conclusion, they recommend discontinuation of the use of nonsteroidal anti-inflammatory drugs in patients with iron deficiency anemia who have LETTERS 507 normal findings on assessment of the upper and lower gas- trointestinal tract. In light of these facts, why did they subject their patient to laparoscopy and bowel resection rather than discontinue the use of ibuprofen and monitor the patient's response? Douglas W. Kirtley, M.D. Lewis-Gale Clinic Roanoke, Virginia In response: We thank Dr. Kirtley for his interest in our case report of a woman with severe iron deficiency anemia, who had been hospitalized numerous times. Laparotomy was done because an angiogram demonstrated angiodysplasia in the cecum, and no other source for the bleeding could be detected. We did not expect to find the multiple strictures in the distal ileum. In fact, this case occurred before the so- called diaphragm disease had been reported by Bjarnason and colleagues. I In addition, the patient had been taking ibuprofen, a nonsteroidal agent that had not previously been associated with drug-induced enteropathy. In light of our current knowledge, we certainly agree that discontinuing the use of ibuprofen and monitoring the patient's response would be a reasonable course of action. Paul Y. Kwo, M.D. William J. Tremaine, M.D. Mayo Clinic Rochester Rochester, Minnesota REFERENCE 1. Bjarnason I, Price AB, Zanelli G, Smethurst P, Burke M, Gumpel JM, et al. Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures. Gastroenterology 1988; 94:1070-1074 The Editor welcomes letters and comments, par- ticularly pertaining to recently published articles in the Mayo Clinic Proceedings. A letter should be no longer than 500 words, contain no more than 5 references, and be in a double-spaced, typewritten format. The letter should be signed. It is assumed that appropriate letters may be published, at the discretion of the Editor, unless the writer indicates otherwise. The Editor reserves the right to edit letters in accordance with the Mayo Clinic Pro- ceedings style and to abridge them ifnecessary. For personal use. Mass reproduce only with permission from Mayo Clinic Proceedings.

Treatment of Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy

Embed Size (px)

Citation preview

Page 1: Treatment of Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy

Mayo Clio Proc, May 1995, Vol 70

nonhemorrhagic stroke; a ventilation/perfusion scan showeda high probability of pulmonary embolism. A correct optionindicated was to begin intravenous heparin therapy to in­crease the activated partial thromboplastin time to 11/2 timesthe normal value and start warfarin therapy the same day. Ibelieve, however, that it is important, especially for teachingpurposes, to consider the option of obtaining a computedtomographic scan of the head. Possibly, a cerebral computedtomographic scan was obtained only during the initial as­sessment of the patient, results of which showed no acutehemorrhage. Thus, the patient's hemiplegia would havebeen regarded as due to a nonhemorrhagic cause. Consider­ing the clinical entity of hemorrhagic transformation of acerebrovascular accident is important. This well-describedentity can occur in previously ischemic brain tissue within10 days after an initial ischemic event.

The initiation of anticoagulant therapy in the presence ofa cerebral hemorrhagic event would be devastating. In myopinion and from my clinical experience, the option of per­forming imaging studies of the head should therefore beconsidered as a first step before instituting anticoagulanttherapy in such a situation.

Martin A. Schaeffer, M.D.DuBois Regional Medical CenterDuBois, Pennsylvania

In response: I agree entirely with Dr. Schaeffer's concernsthat a stroke may not demonstrate hemorrhage for at least 48hours. Thus, obtaining a computed tomographic scan beforeinitiation of long-term anticoagulant therapy would beappropriate.

Edward C. Rosenow III, M.D.Mayo Clinic RochesterRochester, Minnesota

Treatment of Nonsteroidal Anti-InflammatoryDrug-Induced Enteropathy

To the Editor: In the case report by Kwo and Tremaine onnonsteroidal anti-inflammatory drug-induced enteropathy,which was published in the January 1995 issue of the MayoClinic Proceedings (pages 55 to 61), I question their decisionto perform laparotomy in their patient who had persistentanemia. Their article had several references that substanti­ated the effects of nonsteroidal anti-inflammatory drugs onthe small bowel. In the conclusion, they recommenddiscontinuation of the use of nonsteroidal anti-inflammatorydrugs in patients with iron deficiency anemia who have

LETTERS 507

normal findings on assessment of the upper and lower gas­trointestinal tract. In light of these facts, why did theysubject their patient to laparoscopy and bowel resectionrather than discontinue the use of ibuprofen and monitor thepatient's response?

Douglas W. Kirtley, M.D.Lewis-Gale ClinicRoanoke, Virginia

In response: We thank Dr. Kirtley for his interest in our casereport of a woman with severe iron deficiency anemia, whohad been hospitalized numerous times. Laparotomy wasdone because an angiogram demonstrated angiodysplasia inthe cecum, and no other source for the bleeding could bedetected. We did not expect to find the multiple strictures inthe distal ileum. In fact, this case occurred before the so­called diaphragm disease had been reported by Bjarnasonand colleagues. I In addition, the patient had been takingibuprofen, a nonsteroidal agent that had not previously beenassociated with drug-induced enteropathy. In light of ourcurrent knowledge, we certainly agree that discontinuing theuse of ibuprofen and monitoring the patient's responsewould be a reasonable course of action.

Paul Y. Kwo, M.D.William J. Tremaine, M.D.Mayo Clinic RochesterRochester, Minnesota

REFERENCE1. Bjarnason I, Price AB, Zanelli G, Smethurst P, Burke M,

Gumpel JM, et al. Clinicopathological features of nonsteroidalantiinflammatory drug-induced small intestinal strictures.Gastroenterology 1988; 94:1070-1074

The Editor welcomes letters and comments, par­ticularly pertaining to recently published articles inthe Mayo Clinic Proceedings. A letter should be nolonger than 500 words, contain no more than 5references, and be in a double-spaced, typewrittenformat. The letter should be signed. It is assumedthat appropriate letters may be published, at thediscretion of the Editor, unless the writer indicatesotherwise. The Editor reserves the right to editletters in accordance with the Mayo Clinic Pro­ceedings style and to abridge them ifnecessary.

For personal use. Mass reproduce only with permission from Mayo Clinic Proceedings.